MAPT and supranuclear palsy, progressive, 1: Currently, the most recognized genetic risk locus for PSP is at the H1/H2 haplotype region covering MAPT gene at chromosome 17q21.31 [7], where individuals carrying the common H1 haplotype are more likely to develop PSP with an estimated odds ratio (OR) of 5.6 [8].